SVG
Antimicrobial Resistance (AMR)
Antimicrobial resistance (AMR) has been called the silent pandemic. FasterCures seeks to encourage the development of new antibiotics by promoting policies that could incentivize drug developers, investigate ways to bring more private capital into the space, and highlight emerging approaches to treating bacterial infections beyond antibiotics.
Antimicrobial Resistance (AMR)
Related Articles
On the Zero-Draft Resolution of the “Scope, modalities, format and organization of the High Level Meeting on Antimicrobial Resistance convened by the President of the General Assembly”
H.E. Vanessa Frazier Co-Facilitator High-Level Meeting on Anti-Microbial Resistance Permanent Representative of Malta to the UN New York, NY 10016 H.E. Francois Jackman Co-Facilitator High-Level Meeting on Anti-Microbial Resistance...Read Letter
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Discussion Draft - US Senate HELP Committee
Submitted electronically The Honorable Bernie Sanders Chairman HELP Committee United States Senate Washington, DC 20510 The Honorable Bill Cassidy, MD Ranking Member HELP Committee United States Senate Washington, DC 20510 The Honorable...Read LetterImage
Esther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...Read Report
11
Related Videos
A Global Priority: The Fight Against Antimicrobial Resistance2023 Future of Health Summit Session Part 1- A Conversation with US Senators Michael Bennet, Colorado and Todd Young, Indiana2023 Future of Health Summit Session Part 2
What’s Next for the UK’s Subscription Model in the Fight Against Antimicrobial Resistance2023 FasterCures Webinar
Reviving the Antibiotic Pipeline: How Can New Investments and Incentives Beat Superbugs?2021 Global Conference Session
Are Resistant Infections the Next Pandemic? New Antibiotics Need New Incentives2020 Future of Health Summit Session
Superbugs: Avoiding an Existential Threat to Humanity2018 London Summit Session